Compile Data Set for Download or QSAR
maximum 50k data
Found 40 Enz. Inhib. hit(s) with all data for entry = 3491
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261482(US10011568, Ex. No. 5 | US9708266, 5)
Affinity DataIC50:  0.980nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261483(US10011568, Ex. No. 6 | US9708266, 6)
Affinity DataIC50:  1nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261478(US10011568, Ex. No. 1 | US9708266, 1)
Affinity DataIC50:  1.45nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261490(US10011568, Ex. No. 13 | US9708266, 13)
Affinity DataIC50:  1.62nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261484(US10011568, Ex. No. 7 | US9708266, 7)
Affinity DataIC50:  1.63nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261479(US10011568, Ex. No. 2 | US9708266, 2)
Affinity DataIC50:  1.78nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261480(US10011568, Ex. No. 3 | US9708266, 3)
Affinity DataIC50:  2.10nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261491(US10011568, Ex. No. 14 | US9708266, 14)
Affinity DataIC50:  2.21nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261481(US10011568, Ex. No. 4 | US9708266, 4)
Affinity DataIC50:  2.35nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261486(US10011568, Ex. No. 9 | US9708266, 9)
Affinity DataIC50:  2.35nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261497(US10011568, Ex. No. 21 | US9708266, 21)
Affinity DataIC50:  2.36nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261492(US10011568, Ex. No. 16 | US9708266, 16)
Affinity DataIC50:  2.78nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261487(US10011568, Ex. No. 10 | US9708266, 10)
Affinity DataIC50:  2.79nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261496(US10011568, Ex. No. 20 | US9708266, 20)
Affinity DataIC50:  3.27nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261485(US10011568, Ex. No. 8 | US9708266, 8)
Affinity DataIC50:  4.01nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261489(US10011568, Ex. No. 12 | US9708266, 12)
Affinity DataIC50:  4.46nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261495(US10011568, Ex. No. 19 | US9708266, 19)
Affinity DataIC50:  4.96nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261493(US10011568, Ex. No. 17 | US9708266, 17)
Affinity DataIC50:  5.51nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261494(US10011568, Ex. No. 18 | US9708266, 18)
Affinity DataIC50:  6.45nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261488(US10011568, Ex. No. 11 | US9708266, 11)
Affinity DataIC50:  6.75nMAssay Description:The buffer solution for the receptor binding test was dispensed to the wells of a 96-well assay plate (Greiner) at 22.5 μL/well. DMSO solutions ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM50220136(3-[2-{1-[3,5-di(trifluoromethyl)phenyl]ethoxy}-3-(...)
Affinity DataIC50:  20nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
In DepthDetails US PatentDrugBank

TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261489(US10011568, Ex. No. 12 | US9708266, 12)
Affinity DataIC50:  2.20E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261488(US10011568, Ex. No. 11 | US9708266, 11)
Affinity DataIC50:  2.70E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261492(US10011568, Ex. No. 16 | US9708266, 16)
Affinity DataIC50:  3.10E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261493(US10011568, Ex. No. 17 | US9708266, 17)
Affinity DataIC50:  3.30E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261497(US10011568, Ex. No. 21 | US9708266, 21)
Affinity DataIC50:  4.20E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261494(US10011568, Ex. No. 18 | US9708266, 18)
Affinity DataIC50:  4.90E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261496(US10011568, Ex. No. 20 | US9708266, 20)
Affinity DataIC50:  5.50E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261483(US10011568, Ex. No. 6 | US9708266, 6)
Affinity DataIC50:  6.10E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261485(US10011568, Ex. No. 8 | US9708266, 8)
Affinity DataIC50:  6.10E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261479(US10011568, Ex. No. 2 | US9708266, 2)
Affinity DataIC50:  6.80E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261486(US10011568, Ex. No. 9 | US9708266, 9)
Affinity DataIC50:  6.90E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261481(US10011568, Ex. No. 4 | US9708266, 4)
Affinity DataIC50:  7.10E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261491(US10011568, Ex. No. 14 | US9708266, 14)
Affinity DataIC50:  7.50E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261490(US10011568, Ex. No. 13 | US9708266, 13)
Affinity DataIC50:  8.20E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261480(US10011568, Ex. No. 3 | US9708266, 3)
Affinity DataIC50:  9.40E+3nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261484(US10011568, Ex. No. 7 | US9708266, 7)
Affinity DataIC50:  1.10E+4nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261487(US10011568, Ex. No. 10 | US9708266, 10)
Affinity DataIC50:  1.10E+4nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261482(US10011568, Ex. No. 5 | US9708266, 5)
Affinity DataIC50:  1.30E+4nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCytochrome P450 3A4(Homo sapiens (Human))
Kissei Pharmaceutical

US Patent
LigandPNGBDBM261478(US10011568, Ex. No. 1 | US9708266, 1)
Affinity DataIC50:  1.30E+4nMAssay Description:A dimethyl sulfoxide (DMSO) solution of a test compound with a concentration 1000 times higher than the evaluation concentration was prepared, and a ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent